{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:42:48Z","timestamp":1784054568179,"version":"3.55.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.pharep.2013.08.007","type":"journal-article","created":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T17:21:42Z","timestamp":1392830502000},"page":"74-80","source":"Crossref","is-referenced-by-count":74,"title":["Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress"],"prefix":"10.1007","volume":"66","author":[{"given":"C\u00fcneyt","family":"T\u00fcrke\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"S\u00f6y\u00fct","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015e\u00fckr\u00fc","family":"Beydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2013.08.007_bib0005","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/01.ATV.15.11.1812","article-title":"Serum paraoxonase activity, concentration and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins","volume":"15","author":"Abbott","year":"1995","journal-title":"Arterioscler Throm Vas Biol"},{"key":"10.1016\/j.pharep.2013.08.007_bib0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ng1482","article-title":"The evolvability of promiscuous protein functions","volume":"37","author":"Aharoni","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharep.2013.08.007_bib0015","first-page":"225","article-title":"Serum paraoxonase levels in pancreatic cancer","volume":"50","author":"Akcay","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.pharep.2013.08.007_bib0020","first-page":"273","article-title":"Serum paraoxonase levels in gastric cancer","volume":"50","author":"Akcay","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.pharep.2013.08.007_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1042\/bj0530110","article-title":"Serum esterases. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination","volume":"53","author":"Aldridge","year":"1953","journal-title":"Biochem J"},{"key":"10.1016\/j.pharep.2013.08.007_bib0030","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.clinbiochem.2008.06.017","article-title":"Intravenous anesthetics inhibit human paraoxonase-1 (PON1) activity in vitro and in vivo","volume":"41","author":"Alici","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.pharep.2013.08.007_bib0035","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0891-5849(99)00242-7","article-title":"Oxidative stress and gene regulation","volume":"28","author":"Allen","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharep.2013.08.007_bib0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nbd.2010.08.020","article-title":"L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease","volume":"41","author":"Anekonda","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharep.2013.08.007_bib0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1620\/tjem.217.17","article-title":"Decreased serum paraoxonase 1 activity and increased homocysteine and malondialdehyde levels in age-related macular degeneration","volume":"217","author":"Ates","year":"2009","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.pharep.2013.08.007_bib0050","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1161\/01.CIR.101.21.2510","article-title":"Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions","volume":"101","author":"Aviram","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharep.2013.08.007_bib0055","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0891-5849(98)00272-X","article-title":"Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants","volume":"26","author":"Aviram","year":"1999","journal-title":"Free Radic Bio Med"},{"key":"10.1016\/j.pharep.2013.08.007_bib0060","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high density lipoprotein (HDL) oxidation and preserves its functions: a possible peroxidative role for paraoxonase","volume":"101","author":"Aviram","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharep.2013.08.007_bib0065","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2004.06.030","article-title":"Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development","volume":"37","author":"Aviram","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharep.2013.08.007_bib0070","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/01.ATV.19.2.330","article-title":"Serum paraoxonase after myocardial infarction","volume":"19","author":"Ayub","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharep.2013.08.007_bib0075","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.clinbiochem.2005.06.010","article-title":"Assessment of paraooxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis","volume":"38","author":"Baskol","year":"2005","journal-title":"Clin Biochem"},{"key":"10.1016\/j.pharep.2013.08.007_bib0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000089269","article-title":"Serum paraoxonase 1 activity and peroxidation levels in patients with age-related macular degeneration","volume":"220","author":"Baskol","year":"2006","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.pharep.2013.08.007_bib0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0026-0495(00)80077-3","article-title":"What is oxidative stress?","volume":"49","author":"Betteridge","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.pharep.2013.08.007_bib0090","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.mam.2005.07.004","article-title":"Selenium, oxidative stress, and health aspects","volume":"26","author":"Brenneisen","year":"2005","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.pharep.2013.08.007_bib0095","first-page":"2189","article-title":"Effects of some drugs on enzyme activity of glucose 6-phosphate dehydrogenase from chicken erythrocytes in vitro","volume":"20","author":"Ciftci","year":"2008","journal-title":"Asian J Chem"},{"key":"10.1016\/j.pharep.2013.08.007_bib0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ics.2007.02.064","article-title":"Oxidative stress, inflammation and atherosclerotic plaque development","volume":"1303","author":"Cipollone","year":"2007","journal-title":"Int Congr Ser"},{"key":"10.1016\/j.pharep.2013.08.007_bib0105","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1016\/j.bmc.2009.07.019","article-title":"Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I\u2013XIV","volume":"17","author":"Coban","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharep.2013.08.007_bib0110","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1248\/bpb.30.2257","article-title":"Morphine inhibits erythrocyte carbonic anhydrase in vitro and in vivo","volume":"30","author":"Coban","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.pharep.2013.08.007_bib0115","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1681\/ASN.V9112082","article-title":"Decrease of serum paraoxonase activity in chronic renal failure","volume":"9","author":"Dantoine","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharep.2013.08.007_bib0120","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/CS20040187","article-title":"Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-I","volume":"107","author":"Deakin","year":"2004","journal-title":"Clin Sci"},{"key":"10.1016\/j.pharep.2013.08.007_bib0125","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.ATV.21.4.473","article-title":"Paraoxonase and atherosclerosis","volume":"21","author":"Durrington","year":"2001","journal-title":"Arterioscler Thromb Vasc"},{"key":"10.1016\/j.pharep.2013.08.007_bib0130","first-page":"214","article-title":"The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts","volume":"35","author":"Eckerson","year":"1983","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharep.2013.08.007_bib0135","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1080\/14756360802608351","article-title":"Effect of some analgesics on paraoxonase-1 purified from human serum","volume":"24","author":"Ekinci","year":"2009","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.pharep.2013.08.007_bib0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejphar.2009.06.048","article-title":"Evaluation of the impacts of antibiotic drugs on PON 1; a major bioscavenger against cardiovascular diseases","volume":"617","author":"Ekinci","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2013.08.007_bib0145","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12011-009-8500-0","article-title":"Purification of PON1 from human serum and assessment of enzyme kinetics against metal toxicity","volume":"135","author":"Ekinci","year":"2010","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.pharep.2013.08.007_bib0150","first-page":"78","article-title":"Paraoxonase","volume":"35","author":"Ekmekci","year":"2004","journal-title":"Cerrahpa\u015fa J Med"},{"key":"10.1016\/j.pharep.2013.08.007_bib0155","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-5793(92)80383-R","article-title":"Nitrendipine is a potent inhibitor of the Ca2+-activated K+ channel of human erythrocytes","volume":"296","author":"Ellory","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharep.2013.08.007_bib0160","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1210\/jc.2004-0486","article-title":"Paraoxonase activity in high density lipoproteins: a comparison between healthy and obese females","volume":"90","author":"Ferretti","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharep.2013.08.007_bib0165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0009-2797(93)90023-R","article-title":"Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification","volume":"87","author":"Furlong","year":"1993","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.pharep.2013.08.007_bib0170","doi-asserted-by":"crossref","first-page":"10133","DOI":"10.1021\/bi00106a009","article-title":"Purification of rabbit and human serum paraoxonase","volume":"30","author":"Furlong","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharep.2013.08.007_bib0175","doi-asserted-by":"crossref","first-page":"11843","DOI":"10.1021\/bi050862i","article-title":"High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I","volume":"44","author":"Gaidukov","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharep.2013.08.007_bib0180","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0090-9556(25)07065-5","article-title":"Purification of human serum paraoxonase\/arylesterase. Evidence for one esterase catalyzing both activities","volume":"19","author":"Gan","year":"1991","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharep.2013.08.007_bib0185","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jbbm.2007.09.003","article-title":"Simple procedures for purification and stabilization of human serum paraoxonase-1","volume":"70","author":"Golmanesh","year":"2008","journal-title":"J Biochem Biophys Meth"},{"key":"10.1016\/j.pharep.2013.08.007_bib0190","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1084\/jem.168.3.1041","article-title":"Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation","volume":"168","author":"Griffith","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharep.2013.08.007_bib0195","first-page":"1283","article-title":"The inhibitory effect of dantrolene sodium and propofol on 6-phosphogluconate dehydrogenase from rat erythrocyte","volume":"17","author":"Gulcin","year":"2008","journal-title":"Fresenius Environ Bull"},{"key":"10.1016\/j.pharep.2013.08.007_bib0200","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/14756360701474780","article-title":"The inhibitory effect of ethanol on carbonic anhydrase isoenzymes: an in vivo and in vitro study","volume":"23","author":"Gulcin","year":"2008","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.pharep.2013.08.007_bib0205","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0968-0004(90)90206-Q","article-title":"The measurement and mechanism of lipid peroxidation in biological systems","volume":"15","author":"Gutteridge","year":"1990","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.pharep.2013.08.007_bib0210","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nsmb767","article-title":"Structure and evolution of the serum paraoxonase family of detoxifying and antiatherosclerotic enzymes","volume":"11","author":"Harel","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.pharep.2013.08.007_bib0215","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0891-5849(02)01363-1","article-title":"Nitric oxide in cancer and chemoprevention","volume":"34","author":"Hofseth","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharep.2013.08.007_bib0220","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1073\/pnas.0237083100","article-title":"Nitric oxide-induced cellular stress and p53 activation in chronic inflammation","volume":"100","author":"Hofseth","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharep.2013.08.007_bib0225","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2010.07.030","article-title":"Some cardiovascular therapeutics inhibit paraoxonase 1 (PON1) from human serum","volume":"645","author":"Isgor","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2013.08.007_bib0230","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1021\/bi047440d","article-title":"Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase","volume":"44","author":"Khersonsky","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharep.2013.08.007_bib0235","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.ijporl.2011.07.017","article-title":"Paraoxonase and arylesterase activity and total oxidative\/anti-oxidative status in patients with chronic adenotonsillitis","volume":"75","author":"Koc","year":"2011","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.pharep.2013.08.007_bib0240","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1995-7645(10)60075-2","article-title":"Effects of simvastatin on paraoxonase 1 (PON1) activity and oxidative stress","volume":"3","author":"Kumar","year":"2010","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.pharep.2013.08.007_bib0245","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0009-2797(99)00049-6","article-title":"On the physiological role(s) of the paraoxonases","volume":"119","author":"La Du","year":"1999","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.pharep.2013.08.007_bib0250","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0021-9150(00)80184-7","article-title":"Simvastatin increases plasma levels of the antioxidant enzyme paraoxonase by PON1 gene activation","volume":"151","author":"Leviev","year":"2000","journal-title":"Atheroslerosis"},{"key":"10.1016\/j.pharep.2013.08.007_bib0255","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ja01318a036","article-title":"The determination of enzyme dissociation constants","volume":"56","author":"Lineweaver","year":"1934","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pharep.2013.08.007_bib0260","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1365-2362.2002.00977.x","article-title":"Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls","volume":"32","author":"Mackness","year":"2002","journal-title":"Eur Clin Invest"},{"key":"10.1016\/j.pharep.2013.08.007_bib0265","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0306-3623(98)00028-7","article-title":"Human serum paraoxonase","volume":"31","author":"Mackness","year":"1998","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.pharep.2013.08.007_bib0270","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0021-9150(98)00095-1","article-title":"Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity, concentration in non-insulin dependent diabetes mellitus","volume":"139","author":"Mackness","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharep.2013.08.007_bib0275","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80962-3","article-title":"Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein","volume":"286","author":"Mackness","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharep.2013.08.007_bib0280","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0021-9150(94)05524-M","article-title":"HDL, its enzymes and its potential to influence lipid peroxidation","volume":"115","author":"Mackness","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharep.2013.08.007_bib0285","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0021-9150(91)90215-O","article-title":"Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus","volume":"86","author":"Mackness","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharep.2013.08.007_bib0290","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0014-5793(97)01243-X","article-title":"Presence of paraoxonase in human interstitial fluid","volume":"416","author":"Mackness","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharep.2013.08.007_bib0295","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00008571-200110000-00009","article-title":"Paraoxonase genotype modifies the effect of pravastatin on high-density lipoprotein cholesterol","volume":"11","author":"Malin","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.pharep.2013.08.007_bib0300","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/clinchem\/32.4.671","article-title":"Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction","volume":"32","author":"McElveen","year":"1986","journal-title":"Clin Chem"},{"key":"10.1016\/j.pharep.2013.08.007_bib0305","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S1734-1140(09)70146-X","article-title":"Effect of atorvastatin on paraoxonase1 (PON1) and oxidative status","volume":"61","author":"Nagila","year":"2009","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2013.08.007_bib0310","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cbi.2007.01.006","article-title":"Effect of metal ions and calcium on purified PON1 and PON3 from rat liver","volume":"167","author":"Pla","year":"2007","journal-title":"Chem-Biol Interact"},{"key":"10.1016\/j.pharep.2013.08.007_bib0315","series-title":"Pharmacology","author":"Rang","year":"1999"},{"key":"10.1016\/j.pharep.2013.08.007_bib0320","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jchromb.2006.03.029","article-title":"Tandem purification of two HDL-associated partner proteins in human plasma, paraoxonase (PON1) and phosphate binding protein (HPBP) using hydroxyapatite chromatography","volume":"836","author":"Renault","year":"2006","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.pharep.2013.08.007_bib0325","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.sbi.2007.08.008","article-title":"Enzymes as a special class of therapeutic target: clinical drugs and modes of action","volume":"17","author":"Robertson","year":"2007","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.pharep.2013.08.007_bib0330","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/bj20030732","article-title":"Identification of paraoxonase 3 in rat liver microsomes: purification and biochemical properties","volume":"376","author":"Rodrigo","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.pharep.2013.08.007_bib0335","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2004.12.030","article-title":"Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice","volume":"181","author":"Rozenberg","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharep.2013.08.007_bib0340","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2169\/internalmedicine.37.581","article-title":"Serum paraoxonase activity and genotype distribution in Japanese patients with diabetes mellitus","volume":"37","author":"Sakai","year":"1998","journal-title":"Internal Med"},{"key":"10.1016\/j.pharep.2013.08.007_bib0345","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1248\/bpb.29.1559","article-title":"Effects of some antibiotics on paraoxonase from human serum in vitro and from mouse serum and liver in vivo","volume":"29","author":"Sinan","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.pharep.2013.08.007_bib0350","doi-asserted-by":"crossref","first-page":"20963","DOI":"10.1074\/jbc.272.34.20963","article-title":"Low density lipoprotein oxidation and its pathobiological significance","volume":"272","author":"Steinberg","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharep.2013.08.007_bib0355","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1161\/01.ATV.20.9.2113","article-title":"Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients","volume":"20","author":"Tomas","year":"2000","journal-title":"Arterioscl Throm Vas"},{"key":"10.1016\/j.pharep.2013.08.007_bib0360","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejphar.2010.02.039","article-title":"Protective effect of amlodipine against osteoporosis in stroke-prone spontaneously hypertensive rats","volume":"635","author":"Ushijima","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2013.08.007_bib0365","first-page":"336","article-title":"Serbest radikaller, lipit peroksitleri ve organizmada prooksidan\u2013antioksidan dengeyi etkileyen kosullar","volume":"2","author":"Uysal","year":"1998","journal-title":"Klinik Gelisim"},{"key":"10.1016\/j.pharep.2013.08.007_bib0370","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1042\/CS20010111","article-title":"High-density lipoprotein composition and paraoxonase activity in Type I diabetes","volume":"101","author":"Valabhji","year":"2001","journal-title":"Clin Sci"},{"key":"10.1016\/j.pharep.2013.08.007_bib0375","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1172\/JCI118359","article-title":"Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidised low density lipoprotein","volume":"96","author":"Watson","year":"1995","journal-title":"J Clin Invest"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014000139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014000139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:35:14Z","timestamp":1752611714000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2013.08.007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1734114014000139"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2013.08.007","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}